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WHILST depression of the PHA
response in chronic lymphatic leukaemia
(Smith, Cowling and Barker, 1972),
Hodgkin's disease (Trubowitz, Masek and
Del Rosario, 1966) and other malignant
lymphomata (Papac, 1970) is now well
established, the change in non-lymphoid
malignancies remains in doubt. Most
reports indicate that a similar depression
occurs in the non-lymphoid malignancies
(Silk, 1967; Ducos et al., 1970; Garrioch,
Good and Gatti, 1970; Whittaker, Rees
and Clark, 1970; Hann and Takita, 1972)
but there are conflicting data indicating
that the response may be normal (Robin-
son and Hurvitz, 1966; Sutherland, Inch
and McCredie, 1971; Nelson, 1969). Ducos
et al. (1970) have stressed the importance
of performing transformation studies with
more than one dilution to produce the best
differentiation between cancer and control
patients. Fitzgerald (1971) has empha-
sized the need to determine dose-response
curves for phytohaemagglutinin in the
routine investigation of patients with
suspected immune deficiency. In accord-
ance with this view, the whole blood
microculture technique was used to deter-
mine the dose response curves in patients
with carcinoma of the large intestine and
healthy controls.
Twenty-one patients aged 39-81 years
suffering from adenocarcinoma of the
colon and rectum were studied. Age
matched control patients were obtained
from pre-operative surgical patients in
whom there was no evidence of malig-
nancy. All studies were performed before
any surgery was undertaken, as there is
evidence suggesting depression of the
lymphocyte response after surgery (Riddle
and Berenbaum, 1967). Patients receiv-
ing drugs known to depress lymphocyte
transformation, such as steroids (McIntyre
et al., 1969) and cytotoxic drugs (Hersh
and Oppenheim, 1967), were excluded
from the study.
On the day of the experiment at 12.00
hours 10mlofwholebloodwas obtained by
venepuncture from the cancer patient and
and age matched control. It was not
always possible to match the patients for
sex as well as age but this was attempted
when possible. The blood was placed into
sterile tubes containing 400 units of
preservative free heparin (Boots Pharma-
ceuticals).
The culture technique was modified
from that of Junge et al. (1970). Blood
was added to medium 199 (Wellcome)
containing penicillin, streptomycin and
neomycin supplemented with 20% pooled
human AB serum to give a final concen-
tration of 2 X 105 lymphocytes per 5 ml
volume; 5 ml aliquots were dispensed into
115 X 13 mm disposable plastic tissue
culture tubes (Nunclon-Sterilin). Phyto-
haemagglutinin was then added in 0*1 ml
volumes at the following doses: 3000 ,ag,
1000 jag, 100 ,ug, 10 ,ug, 1 jag and 0.1 jug
(Wellcome). Tests were performed in
triplicate at all doses and 3 control tubes
containing no PHA were also set up.
The tubes were incubated in air, vertically
and stationary at 37°C for 5 days. 0 15
,uCi 14[C]thymidine (specific activity
> 50 mCi/mmol) was then added to each
tube and the cells incubated for a further
24 hours.
At the end of the labelling period theI. LAUDER AND G. BONE
cells were filtered on to glass fibre filter
discs (Whatman) and the red cells haemo-
lysed under filtration with 5 ml of ice-
cold 3% acetic acid. The tubes were
washed out with 5 ml ofice cold saline and
the washings added to the appropriate
filter discs. 5 ml of ice-cold 10% tri-
chloroacetic acid was then added to each
disc, followed by a final wash out with
10 ml of absolute methanol. The discs
were allowed to dry before being added to
glass liquid scintillation vials (Johnson
and Jergensen Ltd) containing 5 ml of
scintillation fluid (Nuclear Enterprises).
The tubes were then counted for 10
minutes in a Packard liquid scintillation
counter and, after correction for back-
ground, the results were expressed in
counts per minute (ct/min).
The findings are shown in Table I.
The healthy controls show a rapid rise
from 1 jag to 40 jag with a peak response of
approximately 8000 ct/min between 100
and 1000 ,ag of PHA followed by a rapid
fall at 3000 ,ug. The pattern of the
patients' response is similar up to 10 jag
PHA. Until this point the 2 dose-
response curves are roughly parallel.
When plotted, the curve for the cancer
patients flattens off beyond the 40 jag
level to reach a peak of approximately
2500 ct/min at about 100 j,g. The
standard deviations for both groups are
high, reflecting the great variation which
was seen both in the cancer patients and
the controls.
Even for individual cases considerable
variation was noted in the results from
replicate tubes at each dose level. The
mean coefficient of variation between
individual tubes in triplicate samples for
the study as a whole, including both
cancer patients and controls, was 35%. This figure is distorted by the presence of
occasional sets of tubes in which the
coefficient of variation was considerably
higher. A better index of the overall
variation is given by the median value for
the coefficients of variation, which was
30%o.
Statistical analysis of the results was
performed by both the conventional t-test
on the mean values at each level of
response and by an analysis of variance
on all 3 readings at each level of response
in patients and controls. The results
from the t-test are shown in Table I. There was a statistically significant differ-
ence at the 40 jag, 100 jag and 1000 jag levels ofresponse (P < 0-05; < 0-001 and
< 0*05 respectively). The analysis of
variance showed asignificant effect ofboth
disease and, not surprisingly, dilution of
PHA (P < 0.01). Age did not emerge as
a significant effect.
DISCUSSION
It may be concluded from the results
that there is a statistically highly signifi-
cant depression in lymphocyte transfor-
mation in this group of cancer patients, as
measuredbytheuptake of[14C]thymidine. The results from earlier studies have been
inconclusive. Robinson and Hurvitz
(1966) and Nelson (1969) were unable to
demonstrate any difference in the response to PHA. Ricci, Passaleva and Ricca
(1966), Whittaker et al. (1970), Gatti, Garrioch and Good (1970), Garrioch et al.
(1970), Ducos et al. (1970) and Hann and
Takita (1972) have all shown depression of the response. Sutherland et al. (1970) added to the confusion by stating that, whilst morphological assessment of trans-
formation mayshow nodepression,parallel studiesusingradioactivethymidineuptake
may show quite marked depression in
certain groups ofpatients.
Most of these investigations relied on
a single does ofPHA, though Ducos et al.
(1970) showed that better differentiation
between cancer and control patients can
be obtained by using two or more dilu-
tions. Fitzgerald (1971) found that, in
assessing suspected immune deficiencies, the data from the patient should be
compared with a dose-response curve
obtained from healthy controls. Using a
modified whole blood microculture tech-
nique we have been able to confirm the
benefit of this approach. Sample, Gertner and Chretien (1971) also used
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multiple doses ofPHA but were unable to
show any difference between cancer and
control patients.
The different conclusions in the studies
cited appear to us to be due to (i) the
different culture techniques used, (ii) the
use in most studies of a single concentra-
tion of PHA, (iii) different methods of
assessing the degree oftransformation and
(iv) variation within the patients them-
selves with regard to diagnosis and the
extent of the disease.
Reduction of lymphocyte transforma-
tion to PHA may represent a depression
in " T " lymphocyte function within the
cells themselves or may be due to an
inhibitory plasma or serum factor, as
demonstrated by Silk (1967) and by
Garrioch et al. (1970). The latter
mechanism seems most unlikely in this
study as the amount of plasma incorpor-
ated into each tube is very small indeed
compared with the total volume of tissue
culture fluid andpooled serum. However,
the possibility remains that cells may be
" precoated " with the inhibitor, thus
blocking the PHA receptors. The data of
Al-Sarraf, SardesaiandVaitkevicius (1971)
and Golob et al. (1969) suggest that the
inhibitory effect of cancer serum is likely
to be nonspecific and can be observed in
any allogeneic plasma. Against this view
is the presence of serum inhibitory factors
in other conditions (Gatti, 1971). More
information is obviously needed on this
vital point, but the depressed response
which we have demonstrated in this
group of patients may well be due to an
intrinsic cellular defect.
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Book Review
Public Education About Cancer: Recent
Research and Current Programmes.
(1972) UICC Tech. Report Ser. Vol. 9.
Bratislava: UICC.
Research into the nature, causation,
prevention and cure of many forms of cancer
has conferred enormous benefits during the
present century. Also during the century the
realization has grown that such discoveries
are to little avail ifthe potential patient does
not come under medical care soon enough, or
will not change his behaviour to minimize his
risk ofdeveloping cancer.
Early, well-meaning attempts to frighten
the potential patient into action proved at
best ineffective, and gave rise to the realiza-
tion that man's behaviour-particularly in
relation to matters concerning his health-is
at least as complex and difficult to control as
his physiological processes.
During the last two or three decades
health education of the public about cancer
has therefore become increasingly sophisti-
cated. Among the growing number of publi-
cations dealing with aspects of this problem
the Committee on Public Education of the
Commission on Cancer Control of the UICC
has produced an excellent series of Technical
Reports, of which this, its fourth, has just
been issued. The eight chapters in the book
include an essay on the need for simpler
communications; two studies ofthe attitudes
of women, and their response to cervical
cytology screening programmes; the role of
the general practitioner in cytology screening;
the problem of changing smoking habits;
psychic defences against high fear appeals;
and a final chapter which collates 15 years of
research by many psychologists on the effects
of fear arousal on the way people behave.
An inescapable conclusion to be drawn
from a reading of these throughtful papers is
that there now exists an impressive body of
evidence for the guidance of those pro-
fessionally involved in education about
cancer; and the joint authors, John Wake-
field and Clifton R. Read, rightly point out a
need for all these UICC publications to be
more widely known to health educators and
to sociologists.
This reviewer suggests that they should
also be read by all those-scientists, doctors,
nurses and volunteer workers-who, because
they are known by the lay public to have an
interest in cancer, have thrust upon them an
educative role which is unavoidable.
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